• SPX
  • 5987.37
  • 0.3 %
  • 18.0303
  • DJI
  • 44736.57
  • 0.99 %
  • 440.0586
  • N225
  • 38442
  • -0.87 %
  • -338.1406
  • FTSE
  • 8267.3
  • -0.29 %
  • -24.38
  • IXIC
  • 19054.836
  • 0.27 %
  • 51.1855

US FDA approves Basilea Pharmaceutica's antibiotic

By Reuters   |   Apr 3, 2024 at 03:59 PM EST
US FDA approves Basilea Pharmaceutica's antibiotic

(Reuters) -The U.S. health regulator approved Basilea Pharmaceutica's antibiotic for bacterial infections including multidrug-resistant strains, the FDA said on Wednesday.

The Switzerland-based company was seeking approval of its antibiotic ceftobiprole for the treatment of three conditions - Staphylococcus aureus bacteremia (SAB) as well as acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.

The approval expands options for patients who may have developed a resistance to currently available antibiotics. More than 2.8 million antimicrobial-resistant infections occur each year in the U.S., according to the Centers for Disease Control and Prevention.

The intravenous drug, which will be sold under the brand name Zevtera in the U.S, is an advanced-generation cephalosporin antibiotic, and works against a wide range of Gram-positive bacteria including methicillin-resistant strains, and Gram-negative bacteria.

(Reporting by Sriparna Roy, Unnamalai L and Christy Santhosh in Bengaluru; Editing by Vijay Kishore)

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.